trending Market Intelligence /marketintelligence/en/news-insights/trending/87L0GJpxWg4YipNmfH_5hQ2 content esgSubNav
In This List

Cellular Biomedicine board approves $10M stock repurchase program

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Cellular Biomedicine board approves $10M stock repurchase program

The Cellular Biomedicine Group Inc. board approved a $10 million stock repurchase program.

The stocks will be repurchased through the open market.